Responses
Clinical and epidemiological research
Extended report
Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
Compose a Response to This Article
Other responses
No responses have been published for this article.